Clinical Trials List
2024-11-01 - 2028-12-31
Phase II
Recruiting9
ICD-10I27.2
Other secondary pulmonary hypertension
ICD-10I27.89
Other specified pulmonary heart diseases
ICD-9416.8
Other chronic pulmonary heart diseases
-
Trial Applicant
QPS
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/07/01
Investigators and Locations
Co-Principal Investigator
- 陳昱瑋 無
- 劉明承 無
- WEI-WEN LIN 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Hsiang Chun Lee 無
- 黃天祈 無
- Tsung-Hsien Lin 無
- Ying-Ming Tsai Tsai 無
- 吳韋璁 無
- Jui-Sheng Hsu 無
- Chau-Chyun Sheu 無
- 鄭孟軒 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- YEN-HUNG LIN 無
- 張允中 無
- 吳卓愷 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 蕭富致 Division of Cardiovascular Diseases
- 謝孟亨 Division of Infectious Disease
- Horng-Chyuan Lin Division of Infectious Disease
- 劉原彰 無
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Kang-Ling Wang 醫學研究部
- Jia-Yih Feng Division of Thoracic Medicine
- 張皓智 Division of Cardiovascular Diseases
- 蕭逸函 Division of Thoracic Medicine
- 陳俊谷 Division of Radiology
- Han-Shui Hsu Division of General Surgery
- 蕭慈慧 Division of Thoracic Medicine
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- 林佳淩 無
- Tang-Hsiu Huang 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
65 participants
-
Global
126 participants
